Main description:

This book comprehensively examines chemotherapy-induced peripheral neuropathy (CIPN), a common dose-limiting condition that negatively affects both the quality of life of cancer patients and disease outcomes.

CIPN remains a challenging area for both clinical care and research, as there are multiple unresolved issues. Written by leading international experts, the book discusses the natural history of CIPN, the latest predictors of toxicity, instruments for evaluating symptoms, and prevention/therapeutic strategies, as well as patients' experiences of this common clinical syndrome. Lastly it highlights avenues for future research to enhance our understanding of CIPN.

Providing essential information on the management of CIPN and the latest research in the field, this book is a valuable resource for researchers and healthcare providers working with patients with various malignant diseases.

Contents:

Chapter 1: Natural History of Chemotherapy Induced Neuropathy.

Chapter 2: Predisposing factors for the development of CIPN.

Chapter 3: Evaluation of Chemotherapy-Induced Peripheral Neuropathy.

Chapter 4: Preventive Strategies for Chemotherapy-in-duced Peripheral Neuropathy.

Chapter 5: Prevention of CIPN - Current Clinical Data and Future Directions.

Chapter 6: Treatment of established CIPN: basic science and animal models.

Chapter 7: Pharmacological Treatment of Established CIPN.

Chapter 8: Systematic review of exercise for prevention and management of chemotherapy-induced peripheral neuropathy.

Chapter 9: Clinical and practical recommendations in the use of exercise, physical therapy, and occupational therapy for chemotherapy-induced peripheral neuropathy.

Chapter 10: Natural course of neurotoxicity after immune checkpoint inhibitor (ICI) exposure.
Chapter 11: Ants and Needles and Pins - Living with Neuropathy.